Logos Capital
Executive Summary
Logos Capital is a venture capital firm dedicated to advancing healthcare by investing in transformative therapeutics in the biotechnology sector. Their mission is to identify and support groundbreaking innovations that elevate standards of care and improve patient lives, providing capital and strategic insight to achieve this goal.
- They employ a holistic approach that encompasses clinical, operational, regulatory, and commercial complexities of drug development.
- Their process integrates rigorous clinical underwriting, continuous event tracking, and proactive risk management.
- They are led by a multidisciplinary team with deep expertise across various scientific and business domains.
Snapshot
| Fund Size | N/A USD |
| Stages Focus | Not publicly disclosed |
| Sectors Focus | Biotechnology |
| Portfolio Size | 0 companies |
Investment Thesis
Logos Capital's investment thesis is centered around identifying and investing in transformative therapeutics in the biotechnology sector. They focus on opportunities that present attractive valuations and have the potential to generate meaningful long-term returns for investors.
- Target Founders: Founders with deep expertise in biotechnology, medicine, chemistry, engineering, biology, and data science.
- Sectors: Biotechnology, with a focus on transformative, first-in-class, and best-in-class companies.
- Stage: Not publicly disclosed.
- Check Size: Not publicly disclosed.
- Geography: Not publicly disclosed.
- Deal Criteria: Attractive valuations, significant advancements in patient care, and compelling value.
Team & Activity
Active team contains 0 members (0 partners, 0 founders).
Related Investors